Edgewise Therapeutics CSO sells $25,539 in EWTX stock
Edgewise Therapeutics CSO sells $ 25,539 USD EWTX Stock
Therapeutics
Monopar Therapeutics Stock Hits 52-Week High at $38.91 By Investing.com
Monopar Therapeutics Inc . (NASDAQ: ) stock rose to a 52-week high at $38.91. The company, currently valued at $200 million, has analyst price targets of $37 to $72, according to InvestingPro. This milestone marks a significant period of growth for the company, which has seen its share price skyrocket over the past year. Investors … Read more
Edgewise Therapeutics chief scientific officer sells $2.74 million in stock By Investing.com
Russell Allan J, Chief Scientific Officer of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) recently made a significant sell in the stock. On December 30, 2024, Russell sold 100,000 shares of common stock, earning approximately $2.74 million. The stock was sold at an average price of $27.37, with transactions taking place in a price range of $20.00 to … Read more
Kuehn Law Encourages Investors of Akero Therapeutics, Inc. to Contact Law Firm By Investing.com
NEW YORK, NY–(Newsfile Corp. – December 30, 2024) – Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors Akero Therapeutics, Inc. (NASDAQ: NASDAQ:) breached their fiduciary duties to shareholders. The investigation concerns potential self-employment. Shareholders may have rights to damages and corporate governance reforms. if you are long term … Read more
Vera Therapeutics CEO sells shares worth over $821k By Investing.com
BRISBANE, Calif. — Fordyce Marshall, president and CEO of Vera Therapeutics Inc. (NASDAQ:VERA), recently completed a series of stock transactions, according to a filing with the Securities and Exchange Commission. On December 11th, Marshall sold 17,500 shares of Class A common stock, netting approximately $821,523. Shares were traded at prices ranging from $46.9112 to $47.65. … Read more